PAM
PRTK

Panagora Asset Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Panagora Asset Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-575
Closed -$4K – 2519
2021
Q2 		$4K Sell
575
-2,332
-80% -$18.9K ﹤0.01% 2547
2021
Q1 		$20K Hold
2,907
– – ﹤0.01% 2313
2020
Q4 		$18K Buy
2,907
+1,533
+112% +$9.02K ﹤0.01% 2209
2020
Q3 		$7K Buy
+1,374
New +$6.8K ﹤0.01% 2393
2017
Q4 		– Sell
-49,195
Closed -$1.24M – 2374
2017
Q3 		$1.24M Buy
+49,195
New +$1.15M ﹤0.01% 1041
2016
Q2 		– Sell
-1,524
Closed -$23K – 2362
2016
Q1 		$23K Hold
1,524
– – ﹤0.01% 2123
2015
Q4 		$29K Sell
1,524
-1,358
-47% -$25.9K ﹤0.01% 2093
2015
Q3 		$55K Sell
2,882
-5,613
-66% -$140K ﹤0.01% 1973
2015
Q2 		$219K Sell
8,495
-7,899
-48% -$224K ﹤0.01% 1636
2015
Q1 		$512K Sell
16,394
-1,055
-6% -$30.3K ﹤0.01% 1306
2014
Q4 		$672K Buy
17,449
+3,878
+29% +$92.6K ﹤0.01% 1175
2014
Q3 		$330K Buy
13,571
+2,380
+21% +$62.1K ﹤0.01% 1444
2014
Q2 		$267K Sell
11,191
-405
-3% -$13.2K ﹤0.01% 1621
2014
Q1 		$428K Sell
11,596
-135
-1% -$5.33K ﹤0.01% 1478
2013
Q4 		$473K Buy
11,731
+3,659
+45% +$155K ﹤0.01% 1406
2013
Q3 		$307K Buy
8,072
+422
+6% +$15.1K ﹤0.01% 1503
2013
Q2 		$277K Buy
+7,650
New +$328K ﹤0.01% 1503

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Panagora Asset Management's PRTK Position: Q3 2021 in Review

Panagora Asset Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2021, closing a stake of 575 shares — an estimated $4K sold.

Panagora Asset Management first reported a position in PRTK in Q2 2013 and held it in 17 quarters. The position peaked at $1.24M in Q3 2017. 105 funds tracked by Wall St. Rank hold PRTK as of Q3 2021.

  • Panagora Asset Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 575 Paratek Pharmaceuticals, Inc. shares in Q3 2021, an estimated $4K.
  • Panagora Asset Management first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
  • Panagora Asset Management's Paratek Pharmaceuticals, Inc. position peaked at $1.24M in Q3 2017.
  • 105 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.